Content

Particle Technology for Dry Powder Inhalers

Part of the BTEC Fall 2023 Seminar Series

Friday, Oct. 6, 2023
10:40–11:30 a.m. EST
BTEC room 135
Zoom: go.ncsu.edu/btec_seminar

Dry powder inhaler products deliver drugs that are central to pulmonary disease treatment, notably asthma, chronic obstructive pulmonary and infectious diseases. Drug particle size and morphology is critical to effective aerosol generation and lung deposition where specific receptors involved in broncho-motor tone or the underlying cause of disease, inflammation are targeted. Milling and spray drying are the most frequently employed techniques for the production of respirable particles. Each offers advantages for particular applications. The benefits of specific methods of manufacture of dry powders and combination with inhaler devices will be presented in the context of critical performance characteristics to support disease therapy.

Presented by:
The Biopharmaceutical Manufacturing Interest Group (BMIG)

Speaker

Anthony Hickey Ph.D.
Distinguished Fellow
RTI International